KEGG   DISEASE: 家族性部分型リポジストロフィー
エントリ  
H00420                                                             
名称    
家族性部分型リポジストロフィー
  下位グループ
Kobberling 型リポジストロフィー (FPLD1)
Dunnigan型 リポジストロフィー (FPLD2)
Dunnigan 型様リポジストロフィー (FPLD3)
後天性部分型リポジストロフィー (APLD)
AKT2 変異に伴うリポジストロフィー
  上位グループ
脂肪萎縮症 [DS:H01475]
概要    
Familial partial lipodystrophy (FPL) is a rare autosomal dominant disorder characterized by variable loss of body fat from the extremities as well as from the truncal region. LMNA, PPARG and AKT2 have been identified in association with FPL. However, it is not yet known how these genes cause the disorder. Besides them, additional loci are likely as many FPL patients do not reveal any mutations in these genes. LMNA mutations may affect nuclear function, and may be involved in apoptosis and premature cell death of adipocytes, thus causing lipodystrophy. PPARG, PLIN1, and AKT2 are regulators of adipocyte differentiation. AKT2 is also involved in postreceptor insulin signaling. Thus, mutations in these three genes could result in lipodystrophy. The reason why loss of fat is restricted to partial areas remains unknown. Recently, novel autosomal recessive causes of partial lipodystrophy were reported.
カテゴリ  
先天性代謝異常症
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 05 内分泌, 栄養, 代謝の疾患
  内分泌疾患
   その他のグルコース調節または膵内分泌の疾患
    5A44  インスリン抵抗性症候群
     H00420  家族性部分型リポジストロフィー
パスウェイに基づく疾患分類 [BR:jp08402]
 細胞プロセス
  nt06539  筋細胞の細胞骨格
   H00420  家族性部分型リポジストロフィー
  nt06544  神経刺激性リガンドのシグナリング
   H00420  家族性部分型リポジストロフィー
パスウェイ 
hsa04820  Cytoskeleton in muscle cells
hsa04082  Neuroactive ligand signaling
hsa04210  Apoptosis
hsa04371  Apelin signaling pathway
hsa04152  AMPK signaling pathway
hsa04923  Regulation of lipolysis in adipocytes
hsa03320  PPAR signaling pathway
ネットワーク
nt06539 Cytoskeleton in muscle cells
nt06544 Neuroactive ligand signaling
病因遺伝子 
(FPLD2) LMNA [HSA:4000] [KO:K12641]
(FPLD3) PPARG [HSA:5468] [KO:K08530]
(FPLD4) PLIN1 [HSA:5346] [KO:K08768]
(FPLD5) CIDEC [HSA:63924] [KO:K25878]
(FPLD6) LIPE [HSA:3991] [KO:K07188]
(FPLD7) CAV1 [HSA:857] [KO:K06278]
(FPLD8) ADRA2A [HSA:150] [KO:K04138]
(FPLD9) PLAAT3 [HSA:11145] [KO:K16817]
(APLD) LMNB2 [HSA:84823] [KO:K07611]
AKT2 [HSA:208] [KO:K04456]
リンク   
ICD-11: 5A44
MeSH: D052496
OMIM: 608600 151660 604367 613877 615238 615980 606721 620679 620683 608709
文献    
  著者
Simha V, Garg A
  タイトル
Inherited lipodystrophies and hypertriglyceridemia.
  雑誌
Curr Opin Lipidol 20:300-8 (2009)
DOI:10.1097/MOL.0b013e32832d4a33
文献    
  著者
Garg A, Agarwal AK
  タイトル
Lipodystrophies: disorders of adipose tissue biology.
  雑誌
Biochim Biophys Acta 1791:507-13 (2009)
DOI:10.1016/j.bbalip.2008.12.014
文献    
  著者
Bhayana S, Hegele RA
  タイトル
The molecular basis of genetic lipodystrophies.
  雑誌
Clin Biochem 35:171-7 (2002)
DOI:10.1016/S0009-9120(02)00297-7
文献    
PMID:10587585 (FPLD2)
  著者
Cao H, Hegele RA
  タイトル
Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.
  雑誌
Hum Mol Genet 9:109-12 (2000)
DOI:10.1093/hmg/9.1.109
文献    
PMID:10622252 (FPLD3)
  著者
Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S
  タイトル
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.
  雑誌
Nature 402:880-3 (1999)
DOI:10.1038/47254
文献    
PMID:21345103 (FPLD4)
  著者
Gandotra S, Le Dour C, Bottomley W, Cervera P, Giral P, Reznik Y, Charpentier G, Auclair M, Delepine M, Barroso I, Semple RK, Lathrop M, Lascols O, Capeau J, O'Rahilly S, Magre J, Savage DB, Vigouroux C
  タイトル
Perilipin deficiency and autosomal dominant partial lipodystrophy.
  雑誌
N Engl J Med 364:740-8 (2011)
DOI:10.1056/NEJMoa1007487
文献    
PMID:20049731 (FPLD5)
  著者
Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, Dash S, Hyden CS, Bottomley W, Vigouroux C, Magre J, Raymond-Barker P, Murgatroyd PR, Chawla A, Skepper JN, Chatterjee VK, Suliman S, Patch AM, Agarwal AK, Garg A, Barroso I, Cinti S, Czech MP, Argente J, O'Rahilly S, Savage DB
  タイトル
Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.
  雑誌
EMBO Mol Med 1:280-7 (2009)
DOI:10.1002/emmm.200900037
文献    
PMID:24848981 (FPLD6)
  著者
Albert JS, Yerges-Armstrong LM, Horenstein RB, Pollin TI, Sreenivasan UT, Chai S, Blaner WS, Snitker S, O'Connell JR, Gong DW, Breyer RJ 3rd, Ryan AS, McLenithan JC, Shuldiner AR, Sztalryd C, Damcott CM
  タイトル
Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes.
  雑誌
N Engl J Med 370:2307-2315 (2014)
DOI:10.1056/NEJMoa1315496
文献    
PMID:18237401 (FPLD7)
  著者
Cao H, Alston L, Ruschman J, Hegele RA
  タイトル
Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia.
  雑誌
Lipids Health Dis 7:3 (2008)
DOI:10.1186/1476-511X-7-3
文献    
PMID:27376152 (FPLD8)
  著者
Garg A, Sankella S, Xing C, Agarwal AK
  タイトル
Whole-exome sequencing identifies ADRA2A mutation in atypical familial partial lipodystrophy.
  雑誌
JCI Insight 1:e86870 (2016)
DOI:10.1172/jci.insight.86870
文献    
PMID:37919452 (FPLD9)
  著者
Schuermans N, El Chehadeh S, Hemelsoet D, Gautheron J, Vantyghem MC, Nouioua S, Tazir M, Vigouroux C, Auclair M, Bogaert E, Dufour S, Okawa F, Hilbert P, Van Doninck N, Taquet MC, Rosseel T, De Clercq G, Debackere E, Van Haverbeke C, Cherif FR, Urtizberea JA, Chanson JB, Funalot B, Authier FJ, Kaya S, Terryn W, Callens S, Depypere B, Van Dorpe J, Poppe B, Impens F, Mizushima N, Depienne C, Jeru I, Dermaut B
  タイトル
Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARgamma signaling.
  雑誌
Nat Genet 55:1929-1940 (2023)
DOI:10.1038/s41588-023-01535-3
文献    
PMID:16826530 (APLD)
  著者
Hegele RA, Cao H, Liu DM, Costain GA, Charlton-Menys V, Rodger NW, Durrington PN
  タイトル
Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy.
  雑誌
Am J Hum Genet 79:383-9 (2006)
DOI:10.1086/505885
文献    
PMID:19164855 (AKT2)
  著者
Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, Vottero A, Kanabar D, Charlton-Menys V, Durrington P, Soos MA, Carpenter TA, Lomas DJ, Cochran EK, Gorden P, O'Rahilly S, Savage DB
  タイトル
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.
  雑誌
J Clin Invest 119:315-22 (2009)
DOI:10.1172/JCI37432
LinkDB    

» English version

DBGET integrated database retrieval system